BusinessPROVECTUS BIOPHARMACEUTICALS RECEIVES THIRD CANCER COMBINATION THERAPY PATENT FROM THE UNITED STATES PATENT AND TRADEMARK OFFICEBy Nasdaq OMXDec 14, 2017, 11:00 AM UTC
BusinessFavorable Results from a Multi-Center Analysis of Delcath PHP Therapy to be Published in Journal of Surgical OncologyBy Nasdaq OMXDec 5, 2017, 1:00 PM UTC